Large Molecule Discovery & Development Services

We provide a wide range of discovery and development services for New Biological Entities (NBEs) from our state-of-the-art facility located in Hyderabad, India. At the core of NBE services is a talented team of scientists experienced in the design and delivery of a range of advanced therapeutic modalities such as Monoclonal Antibody (mAb), Antibody Drug Conjugates (ADC), bi-specific antibodies, protein therapeutics, mRNA and CAR-T. We establish and adopt innovative technology platforms for faster, reliable and cost-effective solutions to complex problems throughout the biologics value chain. We have the ability to forward integrate large molecule discovery with clinical manufacturing and beyond.